ClinicalTrials.gg
CompletedNCT05885945DysmenorheaUpdated Jan 29, 2024

Diaphragmmatic Muscle Strength and Balance in Women With Dysmenorhea

An observational study in Dysmenorrhea Primary, sponsored by Catholic University of Murcia. Completed at 1 site in Spain. Open to female participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-01-29.

Sponsored by Catholic University of Murcia · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
23
Ages
18 Years to 65 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 23 studies in Dysmenorrhea with a site in Spain — 3 open to participants now, 4 under way, none of them phase 3. Dysmenorrhea · Spain.

Started
2023
the only one that year
Observational
3 of 23
2 open now
Registered
12th of 23
by date
Lead sponsor
1 of 23
Catholic University of Murcia

Among the 23 studies in Dysmenorrhea with a site in Spain, this one is the only one that started in 2023, is one of 3 observational ones, and was the 12th registered.

Dysmenorrhea

432 studies on the registry are indexed under Dysmenorrhea; 108 are open to participants now.

Browse Dysmenorrhea studies →

Open to participants now

3 of the 23 studies in Dysmenorrhea with a site in Spain are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 59 Dysmenorrhea studies recruiting now, 7 (12%) set no upper age limit and 51 (86%) stop at 75 or younger; 12 take children under 18; 20 take healthy volunteers.

This study: 18 Years to 65 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 23 studies in Dysmenorrhea with a site in Spain, or all of them as a file.
02

Study summary

Analysis of stabilometric and respiratory variables in patients with dysmenorrhea during the first day of the menstrual cycle and any other day outside the cycle.

Read the detailed description

Sociodemographic variables such as age, height, body mass index.

Respiratory variables such as maximum inspiratory pressure (MIP), MIP reference %, and MIP predictive value.

Stabilometric variables we will measure the balance in condition of eyes open and eyes closed bipodal support and eyes open in monopodal support

03

Conditions studied

  • Dysmenorrhea Primary

Browse trials for

Keywords

  • dysmenorrhea
  • diaphragm
  • balance
  • muscular strength
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Women with primary dysmenorrhea

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult women with primary dysmenorrhea.
  • Not having had any type of childbirth (natural, caesarean section, etc).
  • Not be positive in COVID. Antigen test in the last 24 hours or negative PCR in the last 48 hours.

Exclusion criteria

Exclusion Criteria:

  • Receive medical treatment during research.
  • Have any orthopedic, neurological or systemic disease diagnosed other than primary dysmenorrhea.
  • Be in follow-up with any medical treatment that does not be primary dysmenorrhea
  • Women with a history of trauma or surgical treatment who involve the musculoskeletal system in the last year.
  • Use of analgesics in the last 48 hours.
  • Consumption of alcohol in the last 24 hours.
  • Have a history or suspicion of pregnancy.
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
23 participants (actual)
Patient registry
No

Groups and cohorts

  • dysmenorrhea

    primary dysmenorrhea

  • control

    control not pain

06

What researchers measure

Primary outcomes

  1. Balance

    stabilometric variables in bipodal and monopodal support

    Time frame: 2 months

  2. diaphragmatic muscle strength

    diaphragmatic muscle force through the maximum inspiratory pressure in the mouth

    Time frame: 2 months

Secondary outcomes

  1. sociodemographic variables

    sociodemographic variables such as age, body mass index, personal data record, and data record related to pain and dysmenorrhea

    Time frame: 2 monsths

07

Study locations

1 site
  • University Catholic of Murcia
    Guadalupe, Murcia 30107, Spain
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2023 to primary completion in Jun 2023, 3 months.

Of 22 observational studies under Dysmenorrhea, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 47. This study's 3 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
May 23, 2023
First posted
Jun 2, 2023
StartActual
Feb 15, 2023
Primary completionActual
Jun 14, 2023
CompletionActual
Jul 31, 2023
Last update
Jan 29, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05885945
Lead sponsor
Catholic University of Murcia
Responsible party
Felipe León Morillas (Dr., Catholic University of Murcia) — Principal investigator
First posted
Jun 2, 2023
Start date
Feb 15, 2023
Primary completion
Jun 14, 2023
Completion
Jul 31, 2023
Last update
Jan 29, 2024

Study contacts

Felipe León-Morillas
principal investigator · Catholic University of Murcia

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion